Australian industry demands clarity on IVD (in vitro diagnostic) classification
This article was originally published in Clinica
Executive Summary
As the date for the trans Tasman regulatory agency launch draws ever closer, Australian in vitro diagnostics (IVD) manufacturers confess to still being somewhat in the dark about grouping and the associated application fee structure.